Emergency Medicine Reports - September 11, 2011

Target Audience:

This CME activity is intended for emergency physicians and family physicians.


AHC Media is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

Credit Designation:

AHC Media designates this enduring material for a maximum of 2.3 AMA PRA Category 1 CreditsTM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
This activity is approved by the American College of Emergency Physicians for 2.25 hours of ACEP Category 1 credits.
Emergency Medicine Reports has been reviewed and is acceptable for up to 1.5 Prescribed credits by the American Academy of Family Physicians. AAFP accreditation begins 01/01/11. Term of approval is for one year from this date. Credit may be claimed for 1 year from the date of each issue.


Sandra M. Schneider, MD
Professor, Department of Emergency Medicine
University of Rochester School of Medicine
Rochester, New York

J. Stephan Stapczynski, MD
Emergency Medicine Department
Maricopa Medical Center
Phoenix, Arizona

CME Question Reviewer
Roger Farel, MD
Newport Beach, CA

Executive Editor
Shelley Mark

Managing Editor
Leslie Hamlin

Dan Quan, DO
Maricopa Medical Center
Department of Emergency Medicine
Division of Toxicology, Phoenix, AZ.

Daniel Haase, MD
Maricopa Medical Center
Emergency Medicine Residency, Phoenix, AZ.

Rachel Levitan, MD
Maricopa Medical Center
Emergency Medicine Residency, Phoenix, AZ.

Peer Reviewer
Karen N. Hansen, MD, FACEP
Assistant Professor of Emergency Medicine
University of Maryland School of Medicine.


  • Legal Drugs of Abuse


  • Recognize or increase index of suspicion for specific conditions
  • State the epidemiology, etiology, pathophysiology, and clinical features of the entity discussed
  • Apply state-of-the-art diagnostic and therapeutic techniques (including the implications of pharmaceutical therapy discussed) to patients with the particular medical problems discussed.
  • Discuss the differential diagnosis of the entity discussed.
  • Explain both likely and rare complications that may occur.

Financial Disclosure:

To reveal any potential bias in this publication, and in accordance with Accreditation Council for Continuing Medical Education guidelines, we disclose that Sandra M. Schneider, MD (editor) serves on the editorial board for Logical Images. Roger Farel, MD (CME question reviewer) owns stock in Johnson & Johnson. J. Stephan Stapczynski, MD (editor), Dan Quan, DO (author), Daniel Haase, MD (author), Rachel Levitan, MD (author), Karen N. Hansen, MD, FACEP (peer reviewer), Shelley Mark (executive editor), and Leslie Hamlin (managing editor) report no relationships with companies related to the field of study covered by this CME activity.

Copyright 2011 AHC Media LLC. All rights reserved.